Renin-Angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases.

Renin-Angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases. Research Abstract Details 

Research Abstract Table of Contents

Jump to the:

Renin-Angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases. Abstract Text:

Hitoshi Yoshiji,Ryuichi Noguchi,Yasuhide Ikenaka,Mitsuteru Kitade,Kosuke Kaji,Tatsuhiro Tsujimoto,Masahito Uemura,Hiroshi Fukui,Hitoshi Yoshiji,Ryuichi Noguchi,Yasuhide Ikenaka,Mitsuteru Kitade,Kosuke Kaji,Tatsuhiro Tsujimoto,Masahito Uemura,Hiroshi Fukui,

The renin-angiotensin system (RAS) is frequently activated in the patients with chronic liver diseases, and recent studies have shown that RAS plays a pivotal role in the progression of chronic liver diseases, i.e., liver fibrosis and hepatocellular carcinoma (HCC). Angiotensin-II (AT-II) reportedly stimulates contractility and proliferation of the activated hepatic stellate cells, and increases the transforming growth factor-beta (TGF-betabeta expression through angiotensin type-I receptors (AT1-R). Many studies have demonstrated that the clinically used angiotensin-converting enzyme inhibitors (ACE-I) and AT1-R blockers (ARB) significantly attenuated the liver fibrosis development in the experimental studies and clinical practice. AT-II also strongly promotes neovascularization, which plays a pivotal role in tumor development. AT-II induces a potent angiogenic factor; namely, the vascular endothelial growth factor (VEGF). It has been reported that ACE-I significantly attenuated the experimental HCC growth and hepatocarcinogenesis along with suppression of neovascularization. The VEGF expression in the tumor was suppressed by ACE-I, too. The combined treatment of ACE-I with other clinically used agents, such as interferon, imatinib mesylate, and vitamin K, shows more potent inhibitory effects on the development of liver fibrosis and HCC. Since RAS inhibitors are widely used in the clinical practice without serious side effects, they may represent a potential new therapeutic strategy against the progression of chronic liver diseases.

Renin-Angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases. Publishing Authors By Initials

H Yoshiji,R Noguchi,Y Ikenaka,M Kitade,K Kaji,T Tsujimoto,M Uemura,H Fukui,H Yoshiji,R Noguchi,Y Ikenaka,M Kitade,K Kaji,T Tsujimoto,M Uemura,H Fukui,

For similar abstracts research abstracts see: abstracts research

PUBMED ID PMID:

MEDLINE DATE:

Renin-Angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases. Journal Published:

PUBLICATION TYPE: Journal Article

Journal: Current medicinal chemistry

VOLUME: 14

Page Numbers: 2749-54

Journal Abbreviation: Curr. Med. Chem.

ISSN: 0929-8673

DAY: 29

MONTH: 11

YEAR: 2007

Renin-Angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases. Information

Number of References:

LANGUAGE: eng

NlmUniqueID: 9440157

Renin-Angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases. Keywords Mesh Terms:

KEYWORDS:

MESH TERMS:

Chemical & Substance for Abstract: Renin-Angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases. Information

Substance Name:

Registry Number:

Grant and Affiliation Information for Renin-Angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases.

AFFILIATION: Third Department of Internal Medicine, Nara Medical University, Nara, Japan. yoshijih@naramed-u.ac.jp.

Country: Netherlands

AGENCY:

GRANT:

ACRONYM:

MEDLINETA: Curr Med Chem

REFSOURCE:

DATABASENAME:

ACCESSION NUMBER:

Number Hits: 0

Renin-Angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases Related Publications

• 2-Geranyl-1,4-naphthoquinone, a possible intermediate of anthraquinones in a Sesamum indicum hairy root culture.
• A numerical simulation of orthodontic tooth movement produced by a canine retraction spring.
• A numerical simulation of tooth movement produced by molar uprighting spring.
• A potent angiogenic factor, vascular endothelial growth factor, improves the survival of the on-going acute hepatic failure in rats.
• Angiotensin-II and vascular endothelial growth factor interaction plays an important role in rat liver fibrosis development.
• Aortic valve replacement in a patient with myelodysplastic syndrome and interstitial pneumonia.
• Blastocyst production by in vitro maturation and development of porcine oocytes in defined media following intracytoplasmic sperm injection.
• Construction and performance test of SGM-TRAIN at UVSOR.
• Crosstalk between high-molecular-weight adiponectin and T-cadherin during liver fibrosis development in rats.
• Diffusion-weighted imaging predicts postoperative persistence in meningioma patients with peritumoural abnormalities on magnetic resonance imaging.
• Direct comparison between transrectal and transperineal extended prostate biopsy for the detection of cancer.
• Effect of glucose levels during the in vitro culture in synthetic oviduct fluid medium on in vitro development of bovine oocytes matured and fertilized in vitro.
• Effects of quality and developmental stage on the survival of IVF-derived bovine blastocysts cultured in vitro after freezing and thawing.
• Eosinophilic cholecystitis as a rare manifestation of visceral larva migrans.
• Giant parapharyngeal space lipoma: case report and surgical approach.
• Ground based verification of JAXA hardware for life science experiments.
• Health locus of control and use of conventional and alternative care: a cohort study.
• Human D-amino acid oxidase: an update and review.
• Increased von Willebrand Factor Over Decreased ADAMTS13 Activity May Contribute to the Development of Liver Disturbance and Multiorgan Failure in Patients With Alcoholic Hepatitis.
• Muc4 is required for activation of ErbB2 in signet ring carcinoma cell lines.
• Multiple combined indirect procedure for the surgical treatment of children with moyamoya disease. A comparison with single indirect anastomosis and direct anastomosis.
• Neurodegenerative disorders in schizophrenia.
• Obstinate cough as a sole presenting symptom of non-metastatic renal cell carcinoma.
• Preoperative serum testosterone level as an independent predictor of treatment failure following radical prostatectomy.
• Renin-Angiotensin system inhibitors as therapeutic alternatives in the treatment of chronic liver diseases.
• Successful 2-year-long remission following repeated salvage surgery in a patient with chemotherapy-resistant metastatic nonseminomatous germ cell tumor.
• Superior vena cava syndrome caused by supraclavicular lymph node metastasis of renal cell carcinoma.
• T helper type 2 differentiation and intracellular trafficking of the interleukin 4 receptor-alpha subunit controlled by the Rac activator Dock2.
• The HNF-1alpha-SNARE connection.
• [Prostate cancer]